Atlas Trials

Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS

Clinical trial NCT02410200 · COMPLETED

Trial details

NCT number
NCT02410200
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis, Relapsing-Remitting
Start date
2015-09-30
Primary completion
2016-09-23
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.